Medical/Pharmaceuticals

Frost & Sullivan Recognizes Neuromod Devices with the 2023 New Product Innovation Award for Developing a Robust Solution That Meets Tinnitus Patients' Needs

Neuromod Devices uniquely leverages its sophisticated technology to meet tinnitus patients' dynamic needs and strict global regulatory requirements for medical devices. SAN ANTONIO, Oct. 19, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the neuromodulation devices for tinnitus space ...

2023-10-19 01:03 1771

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study

BRENTWOOD, Tenn., Oct. 18, 2023 /PRNewswire/ -- Currax Pharmaceuticals LLC  ("Currax") today announced top-line results from a Cardiovascular Health Outcomes Analysis (HOA). This study evaluated the cardiovascular safety of CONTRAVE®/MYSIMBA®, a weight management drug. The real-world study compare...

2023-10-18 20:00 1712

Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore

GAITHERSBURG, Md., Oct. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced thatSingapore's Health Sciences Authority (HSA) has granted full approval for Novavax's prototype COVID-19 vaccine Nuvaxovi...

2023-10-18 20:00 1580

SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care

The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science BOSTON and ROLLE, Switzerland, Oct. 18, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in da...

2023-10-18 20:00 1775

Seegene Reinforces Commitment to Strong ESG Management with 100% Recyclable, Styrofoam-Free Shipping Boxes

* 100% recyclable package made with eco-friendly and FSC-certified materials to proactively meet evolving global environmental regulations * Patent design provides a 30% increase in load capacity and an up to 52% reduction in transportation costs * This initiative is part of Seegene's effort...

2023-10-18 19:00 2106

Telix reports fourth consecutive quarter of positive operating cash flow

MELBOURNE, Australia, Oct. 18, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended30 September 2023 (Q3 2023). All figures are in AUD$ unless otherwise s...

2023-10-18 15:42 1538

Yuyu Pharma to attend 'CPHI Worldwide 2023'

SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide inBarcelona, Spain from October 24th to October 26th. Yuyu Pharma to attend ‘CPHI Worldwide 2023’ The Yuyu Business Development team will be able to meet...

2023-10-18 15:00 2308

Aculys Pharma delivers positive Phase 3 clinical study interim analysis result of a diazepam nasal spray: an antiepileptic drug for the treatment of epileptic seizures

* These results are from Japan's first domestic Phase 3 clinical trial of an intranasally administered antiepileptic drug for Japanese patients aged 6 to 17 for the treatment of status epilepticus or epileptic seizures that may lead to status epilepticus. * The primary efficacy endpoint was...

2023-10-18 14:00 1437

Bridging the Healthcare Gap in Thailand and Beyond with the Belt and Road Initiative

BANGKOK, Oct. 18, 2023 /PRNewswire/ -- "I have a dream that everyone should have the ability to access medical care equally," says Oraphan Wanacharoen (Ice), BGI Genomics Field Application Scientist. "It's very challenging to achieve such a goal inThailand. With the advanced technology of the com...

2023-10-18 08:21 2248

New Results From HEALEY ALS Platform Trial Show Promise for Treating ALS

MONTREAL, Oct. 18, 2023 /PRNewswire/ -- One of the central challenges of Amyotrophic Lateral Sclerosis ALS research is finding ways to slow the progression of the relentlessly degenerative brain disease. Recently, based on results of theHEALEY ALS Platform Trial, two experimental medications plan...

2023-10-18 03:04 1589

Neurologist Anthony Lang Presents Groundbreaking News on Parkinson's Disease at World Congress of Neurology 2023

MONTREAL, Oct. 18, 2023 /PRNewswire/ -- During a plenary lecture at the 26th World Congress of Neurology, Dr. Anthony Lang, professor of neurology and Jack Clark Chair for Parkinson's Disease Research,University of Toronto, revealed a groundbreaking new model for identifying and studying Parkinso...

2023-10-18 02:59 1587

Bio4t2 announces trial evaluating repeat infusions of CAR-T targeting solid tumors without lymphodepletion

SAN DIEGO and SHANGHAI, Oct. 17, 2023 /PRNewswire/ -- Bio4t2® received regulatory approvals to repeatedly administer patients with T cells engineered to express a chimeric antigen receptor (CAR) targeting BT-001, an antigen on solid tumors identified using the PrismCore™ platform. The CAR-T, term...

2023-10-17 23:17 1921

SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement

ZUG, Switzerland, Oct. 17, 2023 /PRNewswire/ -- SHL Medical ("SHL"), a world-leading solutions provider of advanced drug delivery systems such as autoinjectors and innovative specialty delivery systems, has entered into a non-exclusive co-marketing partnership agreement with Lifecore Biomedica...

2023-10-17 17:00 3668

Docquity pioneers the first regional job platform focused on Southeast Asia's healthcare professionals

* Docquity Jobs enables healthcare organizations to access the region's largest database of medical talent across different specialities * In just one year, the job portal has expanded to four countries with around 400 employers on board * Docquity Jobs has seen a 30% month-on-month growth...

2023-10-17 10:00 3032

World Health Organization Presents Global Action Plan for Neurological Disorders at World Congress of Neurology

MONTREAL, Oct. 16, 2023 /PRNewswire/ -- The World Health Organization (WHO) revealed its new Intersectoral Global Action Plan (IGAP), a critical blueprint for combating neurological conditions that calls for urgent action from governments and health care organizations around the world. IGAP outli...

2023-10-16 22:50 1609

Hong Kong Breast Cancer Foundation - "Pink Walk 2023" Charity Walk Concluded Successfully

Nearly 2,000 Pink Walkers returned to the Peak for Step Up for Breast Health HONG KONG, Oct. 16, 2023 /PRNewswire/ -- The annual flagship fundraising event, "Pink Walk 2023" organised by the Hong Kong Breast Cancer Foundation (HKBCF), was successfully held on 15 October in the Breast Cancer Aware...

2023-10-16 21:01 1877

Fapon and Halodoc Forge Strategic Partnership to Drive the Development of Indonesia's In-Vitro Diagnostics Industry

JAKARTA, Indonesia, Oct. 16, 2023 /PRNewswire/ -- On October 12th, 2023, Fapon, a leading life-science organization, signed a strategic cooperation agreement with Halodoc, the largest telehealth platform inIndonesia. This partnership brings together Fapon's expertise in in-vitro diagnostics (IVD)...

2023-10-16 15:29 2303

Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis

SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Pfizer Inc. (NYSE: PFE) has received approval from the U.S. Food and Drug Administration (FDA) for VELSIPITY™ (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (...

2023-10-16 07:48 1333

UEG Week 2023: Babies with a low birthweight four times more likely to develop fatty liver disease in later life

COPENHAGEN, Denmark, Oct. 16, 2023 /PRNewswire/ -- A groundbreaking new study, presented today at UEG Week 2023, has discovered a significant connection between birthweight and the onset of nonalcoholic fatty liver disease, now known as metabolic dysfunction-associated steatotic liver disease (MA...

2023-10-16 06:01 1969

HEALTHSCOPE : AI ENABLES PATIENT EMOTIONS TO BE ANALYSED IMPROVING HOSPITAL EXPERIENCE.

MELBOURNE, Australia, Oct. 16, 2023 /PRNewswire/ -- A new way to capture patients' emotions is being pioneered by Healthscope to improve how they deliver patient experience following a 3-year study, in what is believed to be a world first by a private hospital. Hospitals rely every day on data s...

2023-10-16 04:00 2344
1 ... 77787980818283 ... 397

Week's Top Stories